Methylcyclopentane

Methylcyclopentane

SCHEMBL5324036

C1CCCC1.CC1CCCC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ EPHX1 P07099 1/20 0.42
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA4 P22748 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ CYP2C9 P11712 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ SHBG P04278 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5430 1.00 — —
SCHEMBL866985 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL7734604 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL133895 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL7912061 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
Cycloheptane SCHEMBL23885013 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL3675505 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL14026664 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
SCHEMBL447245 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2
Cyclohexane SCHEMBL3783181 1.00 ACHE (0.43) ACHEKMT2AEPHX1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007113650-A2 A NOVEL AND IMPROVED PROCESS FRO THE PREPARATION OF NATEGLINIDE AND ITS POLYMORPH FORM-H CADILA PHARMACEUTICALS LIMITED (IN) 2007-10-11 — — WO claimed
WO-2007113650-A2 A NOVEL AND IMPROVED PROCESS FRO THE PREPARATION OF NATEGLINIDE AND ITS POLYMORPH FORM-H CADILA PHARMACEUTICALS LIMITED (IN) 2007-10-11 — — WO disclosed
EP-0903356-B1 CRYSTALLINE POLYPROPYLENE, PROCESS FOR PREPARING THE SAME, POLYPROPYLENE COMPOSITION, AND THERMOFORMED ARTICLE MITSUI CHEMICALS INC (JP) 2005-09-07 — — EP disclosed
US-6403708-B2 THERMOFORMING MITSUI CHEMICALS INC (JP) 2002-06-11 — — US disclosed
US-20010025090-A1 CRYSTALLINE POLYPROPYLENES, PROCESS FOR PREPARING THEROF, POLYPROPYLENE COMPOSITIONS, AND THERMOFORMED PRODUCTS PRIME POLYMER CO., LTD. (JP) 2001-09-27 — — US disclosed
EP-0903356-A1 CRYSTALLINE POLYPROPYLENE, PROCESS FOR PREPARING THE SAME, POLYPROPYLENE COMPOSITION, AND THERMOFORMED ARTICLE Mitsui Chemicals, Inc. (JP) 1999-03-24 — — EP disclosed
US-3962302-A Production of isocyanates from esters of carbamic acids (urethanes) ATLANTIC RICHFIELD COMPANY (US) 1976-06-08 — — US disclosed
Send feedback